Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients

Diabetes

Volumn 49, Issue 7, 2000, Pages 1209-1218

  Henriksen, Jan Erik ^a   Levin, Klaus ^a   Thye Rønn, Peter ^a   Alford, Frank ^c   Hother Nielsen, Ole ^a   Holst, Jens Juul ^b   Beck Nielsen, Henning ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELATIVE;

EID: 0033921461     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.7.1209     Document Type: Article

References (54)

1. Pierce M, Keen H, Bradley C: Risk of diabetes in offspring of parents with noninsulin-dependent diabetes. Diabet Med 12:6-13, 1995
2. Henriksen JE, Alford F, Handberg A, Vaag A, Ward GM, Kalfas A, Beck-Nielsen H: Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus: a novel compensatory mechanism. J Clin Invest 94:1196-1204, 1994
3. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehmstrom BO, Forsen B, Isomaa B, Snickars B, Taskinen MR: Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585-1593, 1996
4. Perseghin G, Ghosh S, Gerow K, Shulnian GI: Metabolic defects in lean non-diabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001-1009, 1997
5. Vaag A, Henriksen JE. Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
6. Schalin-Jantti C, Harkonen M, Groop LC: Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41:598-604, 1992
7. van Haeften TW, Dubbeldam S, Zonderland ML, Erkelens DW: Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects: assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care 21:278-282, 1998
8. Bergman RN: Lilly Lecture 1989: Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes 38:1512-1527, 1989
9. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929, 1992
10. Doi K, Taniguchi A, Nakai Y, Kawamura H, Higaki Y, Yokoi H, Tanaka H, Fujitani J, Suzuki M, Tokuyama K, Sakai M, Fukushima M: Decreased glucose effectiveness but not insulin resistance in glucose-tolerant offspring of Japanese non-insulin-dependent diabetic patients: a minimal-model analysis. Metabolism 46:880-8815, 1997
11. Tobin BL, Finegood DT: Reduced insulin secretion by repeated low doses of STZ impairs glucose effectiveness but does not induce insulin resistance in dogs. Diabetes 42:474-483, 1993
12. Tobin BW, Lewis JT, Tobin BL, Rajotte RV, Finegood DT: Markedly reduced beta-cell function does not result in insulin resistance in islet autografted dogs. Diabetes 41:1172-1181, 1992
13. Finegood DT, Tzur D: Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method. Am J Physiol 271:E485-E495, 1996
14. Caumo A, Vicini P, Cobelli C: Is the minimal model too minimal? Diabetologia 39:997-1000, 1996
15. Caumo A, Giacca A, Morgese M, Pozza G, Micossi P, Cobelli C: Minimal models of glucose disappearance: lessons from the labelled IVGTT. Diabet Med 8:822-832, 1991
16. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte DJ: The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43:587-592, 1994
17. Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, Bergman RN: Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19:1018-1030, 1996
18. Christopher MJ, Rantzau C, Ward GM, Alford FP: Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI. Am J Physiol 268:E410-E421, 1995
19. Ader M, Ni TC, Bergman RN: Glucose effectiveness assessed under dynamic and steady state conditions: comparability of uptake versus production components. J Clin Invest 99:1187-1199, 1997
20. Del Prato S, Matsuda A, Simonson DC, Groop LC, Sheehan P, Leonetti F, Bonadonna RC, DeFronzo RA: Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia 40:687-697, 1997
21. Alzaid AA, Dinneen SF, Turk DJ, Caunio A, Cobelli C, Rizza RA: Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J Clin Invest 94:2341-2348, 1994
22. Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C, Rizza RA: Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes 46:421-132, 1997
23. Nielsen MF, Basu R, Wise S, Cuamo A, Cobelli C, Rizza RA: Normal glucoseinduced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes 47:1735-1747, 1998
24. Mandarino LJ, Consoli A, Jain A, Kelley DE: Differential regulation of intracellular glucose metabolism by glucose and insulin in human muscle. Am J Physiol 265:E898-E905, 1993
25. Sacca L, Hendler R, Sherwin RS: Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. J Clin Endocrinol Metab 47:1160-1163, 1978
26. Mevorach M, Giacca A, Aharon Y, Hawkins M, Shamoon H, Rossetti L: Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 102:744-753, 1998
27. Vaag A, Damsbo P, Hother-Nielsen O, Beck-Nielsen H: Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:80-88, 1992
28. Mandarino LJ, Consoli A, Kelley DE, Reilly JJ, Nurjhan N: Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 71:1544-1551, 1990
29. McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M: Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573, 1976
30. Hother-Nielsen O, Henriksen JE, Staehr P, Beck-Nielsen H: Labelled glucose infusate technique in clamp studies: is precise matching of glucose specific activity important? Endocrinol Metabolism 2:275-287, 1996
31. Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H: Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycemia of NIDDM. Diabetologia 38:326-336, 1995
32. Hemmilä I, Dakubu S, Mukkala V-M, Sütari H, Lövgren T: Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 137:335-343, 1984
33. Hoist JJ: Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-39) of glicentin. Biochem J 207:381-388, 1982
34. Passonneau JV: L-(+)-lactate: fluorometric method. In Methods of Enzymatic Analysis. Bergmeyer HV, Ed. New York, Academic Press, 1974, p. 1468-1472
35. Rossetti L, Giaccari A: Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake: a dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85:1785-1792, 1990
36. Gulli G, Ferrannini E, Stem M, Haffner S, DeFronzo RA: The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575-1586, 1992
37. Hother-Nielsen O, Vaag A, Skott P, Beck-Nielsen H: Effect of hyperglycemia perse on glucose turnover rates in patients with insulin-dependent diabetes. Metabolism 42:86-93, 1993
38. Bak JF, Moller N, Schmitz O: Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Am J Physiol 260:E736-E742, 1991
39. Rose MT, Obara Y, Itoh F, Hashimoto H, Takahashi Y: Growth hormone does not affect non-insulin-mediated glucose uptake in sheep. Exp Physiol 82:749-760, 1997
40. Osei K: Increased basal glucose production and utilization in nondiabetic first-degree relatives of patients with NIDDM. Diabetes 39:597-601, 1990
41. Moller N, Butler PC, Antsiferov MA, Alberti KG: Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32:105-110, 1989
42. Neely RD, Rooney DP, Bell PM, Bell NP, Sheridan B, Atkinson AB, Trimble ER: Influence of growth hormone on glucose-glucose 6-phosphate cycle and insulin action in normal humans. Am J Physiol 263:E980-E987, 1992
43. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lession in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1855-1861, 1995
44. van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE: Impairment of insulin secretion in impaired glucose tolerance. Diabetologia 41:A106, 1998
45. Mitrakou A, Vuorinen-Markkola H, Raptis G, Toft I, Mokan M, Strumph P, Pimenta W, Veneman T, Jenssen T, Bolli G, Korytkowski M, Yki-Jarvinen H, Gerich J: Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp. J Clin Endocrinol Metab 75:379-382, 1992
46. Ader M, Richey JM, Bergman RN: Glucose effectiveness compensates for insulin resistance and inadequate insulin secretion in old rats. Diabetologia 41:A198, 1998
47. Proietto J, Nankervis A, Aitken P, Caruso G, Harewood M, Alford FP: The physiologic action of insulin on glucose uptake and its relevance to the interpretation of the metabolic clearance rate of glucose. Metabolism 32:1022-1028, 1983
48. Baron AD, Brechtel G, Wallace P, Edelman SV: Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol 255:E769-E774, 1988
49. Farrace S, Rossetti L: Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats. Diabetes 41:1453-1463, 1992
50. Kruszynska YT, Home PD, Alberti KG: In vivo regulation of liver and skeletal muscle glycogen synthase activity by glucose and insulin. Diabetes 35:662-667, 1986
51. Galante P, Mosthaf L, Kellerer M, Berti L, Tippmer S, Bossenmaier B, Fujiwara T, Okuno A, Horikoshi H, Haring HU: Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes 44:646-651, 1995
52. Buse MG, Robinson KA, Marshall BA, Mueckler M: Differential effects of GLUT1 or GLUT4 overexpression on hexosamine biosynthesis by muscles of transgenic mice. J Biol Chem 271:23197-23202, 1996
53. Marshall BA, Mueckler MM: Differential effects of GLUT-1 or GLUT-4 overexpression on insulin responsiveness in transgenic mice. Am J Physiol 267:E738-E744, 1994
54. Gulve EA, Ren JM, Marshall BA, Gao J, Hansen PA, Holloszy JO, Mueckler M: Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT1: increased basal transport is associated with a defective response to diverse stimuli that activate GLUT4. J Biol Chem 269:18366-18370, 1994